Lasa Supergenerics

Lasa Supergenerics Interest Coverage

The Interest Coverage Ratio of Lasa Supergenerics (LASA.NS) as of Nov 3, 2026 is -2.24. In the previous year, Interest Coverage Ratio was -4.43 — a change of -49.36% (higher).

Interest Coverage

-2.24

YoY

-49.36%

Last updated:

Interest Coverage Ratio of Lasa Supergenerics is 2025 -2.24 . Interest Coverage Ratio of Lasa Supergenerics was 2024 -4.43 . It decreases by -49.36% higher compared to the previous year.

The Lasa Supergenerics Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
2.45 INR
Jan 1, 2019
-1.10 INR
Jan 1, 2020
1.73 INR
Jan 1, 2021
19.97 INR
Jan 1, 2022
3.60 INR
Jan 1, 2023
-6.64 INR
Jan 1, 2024
-4.43 INR
Jan 1, 2025
-2.24 INR
The Lasa Supergenerics Interest Coverage history
YEARInterest CoverageYoY
-2.24-49.36%
-4.43-33.35%
-6.64-284.34%
3.60-81.96%
19.97+1,051.14%
1.73-258.20%
-1.10-144.81%
2.45-29.61%
3.48—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lasa Supergenerics Stock analysis

What does Lasa Supergenerics do? Lasa Supergenerics Ltd manufactures veterinary preparations including API products such as Albendazole, Fenbendazole, Oxfendazole, Providone Iodine, Nitroxylene, Ricobendazole, Halquinol, and others. The company also produces animal feed ingredients like potassium iodide, cobalt sulfate, sodium selenate, ethylediamine dihydroiodide, and vanadyl sulfate, as well as reagents for therapeutic use including cetylpyridinium chloride, bismuth subsalicylate, and sodium selenite. Its manufacturing facility in Mahad and Chiplun, Maharashtra, supports the production of these specialized veterinary and pharmaceutical products. The company's primary customers are likely veterinary pharmaceutical manufacturers and animal health suppliers who require API products, feed additives, and therapeutic reagents. These segments include the veterinary pharmaceutical industry and animal feed production sectors, which rely on Lasa Supergenerics' specialized chemical formulations for their own product lines. The firm's focus on catalyst chemistry and anthelmintic/veterinary API products positions it within the niche market of veterinary pharmaceutical manufacturing. Lasa Supergenerics generates revenue through the sale of its API products, animal feed ingredients, and therapeutic reagents to veterinary and pharmaceutical companies. The company's product portfolio targets the veterinary pharmaceutical sector, where demand for anthelmintic and other API-based solutions is significant. By specializing in catalyst chemistry and producing high-demand veterinary API products, the company serves a specific market segment with tailored chemical solutions. Lasa Supergenerics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lasa Supergenerics stock

Interest Coverage Ratio of Lasa Supergenerics is -2.24 in 2025.

Interest Coverage Ratio of Lasa Supergenerics changed from -4.43 to -2.24, representing a -49.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Lasa Supergenerics since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Lasa Supergenerics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Lasa Supergenerics

All Key Metrics — Lasa Supergenerics